adaptive trial design AI

Artificial intelligence is rapidly reshaping clinical trial biostatistics, introducing new computational paradigms that extend beyond traditional statistical modeling. In the United States, where regulatory rigor from agencies such as the FDA governs trial design and data integrity, AI integration is emerging as both an opportunity and a compliance challenge. Biostatistics, historically rooted in predefined models … Read more